PHVS

Pharvaris NV (PHVS)

Pharvaris NV

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PHVS

1 2 3 4 5 6 7 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/10/03	19 : 50	GlobeNewswire Inc.	Pharvaris Announces Data Highlighting Deucrictibant for the Treatment of HAE to be Presented at the 2024 HAEi Global Leadership Workshop	NASDAQ:PHVS	Pharvaris NV
2024/09/25	19 : 50	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHVS	Pharvaris NV
2024/09/23	19 : 51	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHVS	Pharvaris NV
2024/09/21	05 : 27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PHVS	Pharvaris NV
2024/09/20	07 : 45	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PHVS	Pharvaris NV
2024/09/20	07 : 44	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PHVS	Pharvaris NV
2024/09/20	05 : 27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PHVS	Pharvaris NV
2024/09/17	05 : 46	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PHVS	Pharvaris NV
2024/09/05	19 : 51	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHVS	Pharvaris NV
2024/09/05	19 : 50	GlobeNewswire Inc.	Pharvaris Provides Business Update and Expands Development Program for Deucrictibant	NASDAQ:PHVS	Pharvaris NV
2024/09/05	19 : 49	GlobeNewswire Inc.	Pharvaris Presents Deucrictibant Long-Term Extension Data for Both the Prophylactic and On-Demand Treatment of HAE at the Bradykinin Symposium 2024	NASDAQ:PHVS	Pharvaris NV
2024/09/05	19 : 48	GlobeNewswire Inc.	Pharvaris Presents Data at the Bradykinin Symposium 2024	NASDAQ:PHVS	Pharvaris NV
2024/08/28	19 : 50	GlobeNewswire Inc.	Deucrictibant Clinical, Real-World, Nonclinical, and Discovery Data to be Presented at the Bradykinin Symposium	NASDAQ:PHVS	Pharvaris NV
2024/08/14	19 : 51	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHVS	Pharvaris NV
2024/08/14	19 : 50	GlobeNewswire Inc.	Pharvaris Reports Second Quarter 2024 Financial Results and Provides Business Update	NASDAQ:PHVS	Pharvaris NV
2024/06/11	19 : 52	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHVS	Pharvaris NV
2024/06/11	19 : 50	GlobeNewswire Inc.	Pharvaris Announces Annual Meeting of Shareholders	NASDAQ:PHVS	Pharvaris NV
2024/06/05	05 : 05	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHVS	Pharvaris NV
2024/06/04	19 : 50	GlobeNewswire Inc.	Pharvaris Highlights Properties of Deucrictibant in Data Presentations at Recent Congresses	NASDAQ:PHVS	Pharvaris NV
2024/05/25	06 : 04	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PHVS	Pharvaris NV
2024/05/23	06 : 54	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PHVS	Pharvaris NV
2024/05/13	19 : 50	GlobeNewswire Inc.	Pharvaris to Present Clinical and Nonclinical Data at Upcoming Congresses	NASDAQ:PHVS	Pharvaris NV
2024/05/09	05 : 11	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:PHVS	Pharvaris NV
2024/05/09	05 : 10	GlobeNewswire Inc.	Pharvaris Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:PHVS	Pharvaris NV
2024/04/11	05 : 10	GlobeNewswire Inc.	Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:PHVS	Pharvaris NV
2024/04/11	05 : 08	GlobeNewswire Inc.	Pharvaris Appoints David Nassif, J.D., as Chief Financial Officer	NASDAQ:PHVS	Pharvaris NV
2024/04/04	19 : 50	GlobeNewswire Inc.	Pharvaris to Present Deucrictibant Clinical Data at the CIIC Spring 2024 Conference	NASDAQ:PHVS	Pharvaris NV
2024/03/18	19 : 50	GlobeNewswire Inc.	Pharvaris Announces Phase 3 Clinical Study Design for Recently Initiated RAPIDe-3 Study, and Presents Quality-of-Life Improvement and Caregiver Behavior Data at Two Recent HAE Congresses	NASDAQ:PHVS	Pharvaris NV
2024/03/12	02 : 51	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PHVS	Pharvaris NV
2024/03/07	06 : 40	Edgar (US Regulatory)	Form F-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NASDAQ:PHVS	Pharvaris NV